Open original FDA record ↗Recall record
- FDA identifier
- Z-0739-2023
- Company in FDA record
- Abbott Molecular, Inc.
- FDA classification date
- Dec 20, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Reports of an increase in reactive negative controls and false positive results with certain lots of Alinity M Resp-4-Plex AMP kits.
Source facts
- Action
- Abbott Molecular issue an Urgent Field Safety Notice /Field Correction Recall to its consignees on 11/22/2022 by FedEx priority express. The notice explained the issue and requested the following actions: "- Discard inventory of any lots listed in Appendix A below. Contact Abbott Customer Support for credit of any unused kit(s). - If you have forwarded any kits of these lots to other laboratories, please inform them of this Urgent Field Safety Notice /Field Correction Recall, and provide a copy of this letter. - Return the associated Customer Reply form. Please review this information with laboratory personnel and retain this communication for future reference. If you have any questions regarding this communication, please contact your local Abbott representative, or call Abbott Technical Support at 1-800-55-7042 Option 2."
- Initiated
- 2022-11-22
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide
- Recall number
- Z-0739-2023
- Recall status
- Open, Classified
- CDRH record ID
- 197251
- FDA classified
- 2022-12-20
- Recall event number
- 91202